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In this study, we investigated the pH dependency of the in vitro activities of amphotericin B (AMB) and
flucytosine (5FC) against Candida spp., Cryptococcus neoformans, Aspergillus fumigatus, Rhizopus spp., and
Scedosporium prolificans in RPMI 1640 buffered with citrate buffer (pH 4.0, 5.0, 5.4, and 6.0), citrate-phosphate
buffer (pH 5.4, 6.0, 6.4, and 7.0), and 3-[N-morpholino]propanesulfonic acid (MOPS) (pH 6.4, 7.0, 7.4, and 7.9).
For 5FC, no significant differences were found between MICs obtained with the different buffers, while for
AMB, significant differences were found. The MICs obtained with citrate-phosphate buffer were approximately
1 twofold-dilution step higher than the MICs obtained with MOPS. We demonstrated that the in vitro activities
of AMB and 5FC against yeast and mold isolates were pH dependent. The in vitro activity of AMB decreased
when the pH was lowered, while the in vitro activity of 5FC increased. The effect of the pH on the in vitro
activities was dependent not only on the antifungal agent tested but also on the microorganism. For AMB, there
was a nonlinear relationship (median r2, 0.864) for Candida spp., C. neoformans, A. fumigatus, and Rhizopus spp.
over the pH range tested. The mean MICs ranged from 0.5 to 2.52 g/ml at pH 7.0 and from 20.16 to 32 g/ml
at pH 5.0. For S. prolificans, there was no relationship. For 5FC, there was a linear relationship for Candida spp.
(median r2, 0.767) and a nonlinear relationship for C. neoformans and A. fumigatus (median r2, 0.882) over the
pH range tested. The mean MIC values ranged from 0.125 to 1,024 g/ml at pH 7.0 and from 0.02 to 4 g/ml
at pH 5.0. For Rhizopus spp. and S. prolificans, the relationship could not be determined, since the MIC was
>1,024 g/ml over a pH range of 4.0 to 7.9.
In vitro susceptibility testing can be used to help predict
outcomes in the treatment of invasive fungal infections. A
good standard in vitro susceptibility test has to provide repro-
ducible results, detect the resistance of fungi, and correlate
with clinical outcome (10). There are many factors involved,
which have made it difficult to develop and standardize in vitro
susceptibility tests for fungi. Some of these factors are inherent
to the antifungal agents, and others are related to the test
conditions. Taking into account all these factors, the Clinical
and Laboratory Standards Institute (CLSI; formerly the Na-
tional Committee for Clinical Laboratory Standards) has pub-
lished standard methods for the in vitro antifungal susceptibil-
ity testing of yeast (M27-A2) and of filamentous fungi (M38-A)
(7, 8).
Although the standardized CLSI method has been found to
give better inter- and intracenter reproducibility, in vitro anti-
fungal susceptibility testing is still faced with several problems,
such as the poor correlation of in vitro results with clinical
outcomes for some organism-drug combinations. The poor
correlation may be partly due to various factors related to the
host, drugs, fungus, and their interactions (16), such as the
recovery of granulocytes, which play roles in clinical outcome
but are not taken into account in the in vitro susceptibility
tests. It may also be partly due to various variables, such as pH,
which may influence the activity of antifungal agents and which
deviate significantly from the clinical situation for in vitro sus-
ceptibility tests (5).
Viviani et al. demonstrated that the MICs of flucytosine
(5FC) against Cryptococcus neoformans obtained in yeast ni-
trogen base (YNB) buffered at pH 5.4 correlated well with
clinical outcome, while the MICs obtained in YNB buffered at
the standard pH value of 7.0 did not (15). We also demon-
strated that the MICs of 5FC against Aspergillus fumigatus
obtained in RPMI 1640 buffered at pH 5.0 correlated better
with in vivo efficacy in a murine model of invasive aspergillosis
than the MICs obtained in RPMI 1640 buffered at the standard
pH value of 7.0 did (D. T. A. te Dorsthorst, J. W. Mouton,
J. F. G. M. Meis, and P. E. Verweij, Abstr. 44th Intersci. Conf.
Antimicrob. Agents Chemother., abstr. M-225, 2004).
In another study, we looked at the influence of pH on the in
vitro activity of antifungal agents. We demonstrated that the in
vitro antifungal activities of amphotericin B (AMB), itracon-
azole, and 5FC against A. fumigatus, A. flavus, and A. terreus
changed at low pH (14). For both AMB and itraconazole, the
in vitro activity decreased when the pH was lowered from 7.0
to 5.0, while for 5FC, the in vitro activity increased when the
pH was lowered.
In this study, we investigated whether the same changes were
found for the in vitro activity of AMB and 5FC against other
molds (Rhizopus spp. and Scedosporium prolificans) and yeasts
(Candida spp. and C. neoformans) when the pH was lowered
from 7.0 to 5.0. In addition, we studied the changes in in vitro
activity over a pH range of 4.0 to 7.9 to more precisely deter-
mine pH dependency.
(Results of this investigation were partly presented at the
* Corresponding author. Mailing address: Department of Medical
Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital,
Weg door Jonkerbos 100, 6532 SZ Nijmegen, The Netherlands. Phone:
31-(0)24-3657514. Fax: 31-(0)24-3657516. E-mail: mouton@cwz.nl.
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13th European Congress of Clinical Microbiology and Infec-
tious Diseases, Glasgow, Scotland, 2003.)
MATERIALS AND METHODS
Isolates. Four clinical yeast isolates (two Candida krusei and two C. neofor-
mans isolates), six clinical mold isolates (two A. fumigatus, one Rhizopus micro-
sporus var. rhizopodiformis, one Rhizopus oryzae, and two S. prolificans isolates),
and two control strains (Candida parapsilosis ATCC 22019 and C. krusei ATCC
6258) were tested. The clinical isolates were obtained from the private collection
of the Department of Medical Microbiology, Radboud University Nijmegen
Medical Center, The Netherlands. Isolates had been frozen in glycerol broth at
80°C. Yeast isolates were revived by subculturing twice on Sabouraud dextrose
agar plates supplemented with 0.5% chloramphenicol for 24 h and 48 h for the
Candida spp. and C. neoformans, respectively, at 35°C. Mold isolates were re-
vived by subculturing twice on Sabouraud dextrose agar tubes for 5 to 7 days at
35°C. All isolates were tested in triplicate on different days.
Medium. RPMI 1640 medium (with L-glutamine and without bicarbonate)
(GIBCO BRL, Life Technologies, Woerden, The Netherlands) was buffered to
pH 4.0, 5.0, 5.4, and 6.0 with 10 mM citrate buffer, to pH 5.4, 6.0, 6.4, and 7.0 with
10 mM citrate-phosphate buffer, and to pH 6.4, 7.0, 7.4, and 7.9 with 0.165
mol/liter 3-[N-morpholino]propanesulfonic acid (MOPS; Sigma-Aldrich Chemie
GmbH, Steinheim, Germany).
Antifungal agents. AMB (Bristol-Myers Squibb, Woerden, The Netherlands)
and 5FC (Valeant, Zoetermeer, The Netherlands) were obtained as powders.
AMB was dissolved in dimethyl sulfoxide at a concentration of 3,200 g/ml, and
5FC was dissolved in distilled water at a concentration of 6,400 g/ml to prepare
stock solutions. The stock solutions were held at 80°C until use.
Susceptibility testing. MICs were determined by a broth microdilution method
according to CLSI guidelines (M27-A2 and M-38A) (7, 8), with the exception
that other buffers were used where necessary (see “Medium” above). Briefly,
serial twofold dilutions of the antifungal agents were prepared in RPMI 1640
medium. The final concentrations of the antifungal agents ranged from 0.001 to
256 g/ml for AMB and from 0.001 to 1,024 g/ml for 5FC. Aliquots of 100 l
of the drugs at concentrations of two times the targeted final concentrations were
dispensed in the wells of flat-bottomed 96-well microtiter plates (Costar, Corn-
ing, NY).
Cell and spore suspensions were prepared spectrophotometrically and were
further diluted in RPMI 1640 medium. In order to obtain final inoculum con-
centrations of 5.0  102 to 2.5  103 cells/ml for the yeast isolates and 0.4  104
to 5  104 conidia/ml for the mold isolates, 100-l portions of the inocula were
added to the wells. The microtiter plates were incubated at 35°C for 72 h.
After 24 h (Rhizopus spp.), 48 h (Candida spp. and A. fumigatus), and 72 h (C.
neoformans and S. prolificans), growth was assessed spectrophotometrically at
405 nm with a microplate reader (Anthos htIII; Anthos Labtec Instruments,
Salzburg, Austria). The optical densities (ODs) of the blanks, which consisted of
uninoculated plates incubated together with the inoculated plates, were sub-
tracted from the ODs of the inoculated plates. The percentage of growth for each
well was calculated by comparing the OD of the well with that of the drug-free
control based on the following equation: (OD of drug-containing well/OD of the
drug-free well)  100%. For AMB, the lowest concentration that showed no
more than 10% of growth in comparison to the growth control (MIC-0) (6) and,
for 5FC, the lowest concentration that showed no more than 50% of growth in
comparison to the growth control (MIC-2) were taken as MIC endpoints (7, 8).
Analysis of results. In order to approximate normal distributions, the drug
concentrations were transformed by logarithmic transformation to log2 values,
and these values were used for the analysis of the results. The high and low
off-scale MICs were included by converting to the next-higher and -lower twofold
drug concentrations, respectively.
(i) Effect of pH on the MICs. In order to determine whether there were
changes in the in vitro activities of AMB and 5FC when the pH was lowered from
7.0 to 5.0, the difference in in vitro activities was calculated. For each isolate, the
mean log2 MIC at pH 7.0 was subtracted from the mean log2 MIC at pH 5.0. The
differences in in vitro activities were given in twofold-dilution steps.
In order to determine pH dependency, we studied the changes in the in vitro
activities over a pH range of 4.0 to 7.9. For each isolate, the relationship between
the in vitro activities of AMB and 5FC and the pH was determined by linear or
nonlinear regression analysis. Nonlinear regression was done by using a four-
parameter logistic model (sigmoid curve with variable slope) known as the Emax
model. The 50% effective concentration (EC50) [pH value that gives the MIC
equaling the maximal MIC 0.5 (the maximal MIC the minimal MIC)], the
EC20 [pH value that gives the MIC equaling the maximal MIC  0.8  (the
maximal MIC  the minimal MIC)], and the EC80 [pH value that gives the MIC
equaling the maximal MIC  0.2  (the maximal MIC  the minimal MIC)]
were calculated. For both linear and nonlinear regressions, the goodness of fit
was checked by the r2 values and residuals. Analysis was carried out using the
GraphPad Prism Software (San Diego, Calif.).
(ii) Effect of buffer on the MIC. In order to determine whether there were
statistically significant differences between MICs obtained with the different
buffers, the log2 MICs of AMB and 5FC obtained with citrate buffer at pH 5.4
and 6.0 were compared with the log2 MICs obtained with citrate-phosphate
buffer at pH 5.4 and 6.0. Also, the log2 MICs obtained with citrate-phosphate
buffer at pH 6.4 and 7.0 were compared with the log2 MICs obtained with MOPS
at pH 6.4 and 7.0. Results were analyzed by the Mann-Whitney U test (AMB) or
the unpaired t test (5FC). Statistical significance was defined as P  0.01.
RESULTS
Almost all isolates grew well in RPMI 1640 buffered to pHs
ranging from 4.0 to 7.9 after 24 to 72 h of incubation at 35°C.
With the exception of the two C. neoformans isolates, the OD
values of the growth controls of the other isolates (after sub-
traction of the OD values of the blanks) were higher than 0.1.
The MICs of AMB and 5FC found at pH 7.0 for the two
control strains were within the limits recommended by the
CLSI (7, 8).
Effect of pH on the MICs. In general, the MIC of AMB
increased when the pH was lowered, while the MIC of 5FC
decreased when the pH was lowered.
Table 1 shows the susceptibilities of the 12 isolates to AMB
and 5FC determined at pH 7.0 (buffered with MOPS) and at
pH 5.0 (buffered with citrate buffer). For the Candida sp., C.
neoformans, A. fumigatus, and Rhizopus sp. isolates, the mean
MICs of AMB increased by 3 to 6 twofold-dilution steps when
the pH was lowered from 7.0 to 5.0, while for the S. prolificans
isolates, the mean MIC decreased with 2 twofold-dilution steps
when the pH was lowered. The relationships between the in
vitro activities of AMB and the pH over a range of 4.0 to 7.9 for
the 12 isolates were determined by regression analysis (see
Table 2). For the Candida sp. isolates, C. neoformans AZN
467, the A. fumigatus isolates, and R. microsporus var. rhizopo-
diformis AZN 1185, nonlinear relationships were found. The
Emax model fitted the data well, since the r
2 values ranged from
0.745 to 0.918 (median, 0.864). For C. neoformans AZN 9019
and R. oryzae AZN 6373, there were also relationships between
the in vitro activities and the pH, but this could not be con-
firmed by regression analysis. For the S. prolificans isolates, no
relationship was found. Figure 1 shows the relationships be-
tween the in vitro activities of AMB and the pH over a range
of 4.0 to 7.9 for C. neoformans AZN 467, A. fumigatus AZN
8196, and S. prolificans AZN 7901.
For the Candida sp. isolates and C. neoformans AZN 467,
the mean MICs of 5FC decreased with 3 to 5 twofold-dilution
steps, and for the A. fumigatus isolates, the mean MIC de-
creased with 11 twofold-dilution steps when the pH was low-
ered from 7.0 to 5.0, while for C. neoformans AZN 9019, the
mean MICs were almost identical at pH 7.0 and at pH 5.0. For
the Rhizopus sp. and S. prolificans isolates, the difference could
not be determined, because high off-scale MICs (mean MIC 
1,024 g/ml) were found at both pH 7.0 and pH 5.0. The
relationships between the in vitro activities of 5FC and the pH
over a range of 4.0 to 7.9 for the 12 isolates were also deter-
mined by regression analysis (see Table 2). For the Candida sp.
isolates, a linear relationship was found. The model fitted the
data well, since the r2 values ranged from 0.681 to 0.906 (me-
dian, 0.767). The slopes ranged from 1.08 to 2.30 (median,
1.91) and significantly deviated from zero (P  0.01). For C.
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neoformans AZN 467 and the A. fumigatus isolates, nonlinear
relationships were found. The Emax model fitted the data well,
since the r2 values ranged from 0.822 to 0.927 (median, 0.882).
For C. neoformans AZN 9019, there was also a relationship
between the in vitro activity and the pH, but this could not be
confirmed by regression analysis. For the Rhizopus spp. and S.
prolificans isolates, the relationships could not be determined
because high off-scale MICs (MIC  1,024 g/ml) were found
at all pH values. Figure 2 shows the relationships between the
in vitro activity of 5FC and the pH over a range of 4.0 to 7.9 for
C. krusei AZN 1_31, C. neoformans AZN 467, A. fumigatus
AZN 8196, and S. prolificans AZN 7901.
Effect of buffer on the MIC. For AMB, there was no signif-
icant difference between MICs obtained with citrate buffer and
with citrate-phosphate buffer (P  0.01). The mean MICs
obtained with citrate buffer and citrate-phosphate buffer were
33.82 and 32.67 g/ml, respectively, at pH 5.4 and 22.16 and
19.43 g/ml, respectively, at pH 6.0. There was a significant
difference between the MICs obtained with citrate-phosphate
buffer and those obtained with MOPS (P  0.01). The MICs
obtained with citrate-phosphate buffer were approximately 1
twofold-dilution step higher than the MICs found with MOPS.
The mean MICs obtained with citrate-phosphate and MOPS
were 7.84 and 3.41 g/ml, respectively, at pH 6.4 and 6.68 and
2.43 g/ml, respectively, at pH 7.0.
For 5FC, the results of the Rhizopus sp. and S. prolificans
isolates were not used, because high off-scale MICs were found
(MIC 1,024 g/ml). For the Candida sp., C. neoformans, and
A. fumigatus isolates, there were no significant differences be-
tween MICs obtained with citrate buffer and those obtained
with citrate-phosphate buffer or with citrate-phosphate buffer
and with MOPS (P  0.01). The mean MICs obtained with
TABLE 1. Susceptibilities of six yeast and six mold isolates to AMB and 5FC determined in RPMI 1640 buffered at pH 7.0 and 5.0a
Isolate
Mean (range) MIC (g/ml)
Difference in in vitro
activity found when
pH was lowered
from 7.0 to 5.0
(twofold dilutions)b
AMB 5FC
AMB 5FCc
pH 7.0 pH 5.0 pH 7.0 pH 5.0
C. parapsilosis ATCC 22019 0.79 (0.5–1) 32 0.125 0.02 (0.016–0.031) 5.33 2.65
C. krusei ATCC 6258 1.26 (1–2) 25.4 (16–32) 6.35 (4–8) 0.5 4.33 3.67
C. krusei AZN 1_31 2.52 (2–4) 25.4 (16–32) 8 (2–64) 0.79 (0.5–1) 3.33 3.33
C. krusei AZN 2_12 2 32 4 (2–16) 0.2 (0.031–0.5) 4 4.34
C. neoformans AZN 467 0.79 (0.5–1) 25.4 (16–32) 2 0.05 (0.031–0.125) 5 5.34
C. neoformans AZN 9019 0.63 (0.5–1) 25.4 (16–32) 5.04 (1–32) 4 5.33 0.33
A. fumigatus AZN 58 0.79 (0.5–1) 32 1.024 0.5 (0.25–1) 5.33 11
A. fumigatus AZN 8196 1 32 80.53 (32–128) 0.031 5 11.34
R. microsporus var.
rhizopodiformis AZN 1185
0.5 20.16 (16–32) 1,024 1,024 5.33 NDc
R. oryzae AZN 6373 0.5 25.4 (16–32) 1,024 1,024 5.67 ND
S. prolificans AZN 7989 322.54 (256–256) 101.59 (64–256) 1,024 1,024 1.67 ND
S. prolificans AZN 7901 256 (128–256) 64 (32–128) 1,024 1,024 2 ND
a RPMI 1640 medium was buffered to pH 7.0 with MOPS and to pH 5.0 with 10 mM citrate buffer.
b The differences were calculated by subtracting the mean log2 MICs found at pH 7.0 from the mean log2 MICs found at pH 5.0.
c ND, not done because high off-scale MIC values (MIC 1,024 g/ml) were found at pH 7.0 and at pH 5.0.
TABLE 2. Results of regression analysis of the relationships between the MICs of AMB and 5FC and the pH over a range of 4.0 to 7.9
Isolate
Relationship between log2 MIC and pHa
AMB 5FC
r2 EC50 EC20 EC80 r2 EC50 EC20 EC80
C. parapsilosis ATCC 22019 0.898 6.35 6.84 5.87 0.708 L L L
C. krusei ATCC 6258 0.838 6.62 7.30 5.94 0.906 L L L
C. krusei AZN 1_31 0.745 6.33 7.28 5.38 0.681 L L L
C. krusei AZN 2_12 0.918 6.77 7.58 5.95 0.826 L L L
C. neoformans AZN 467 0.873 6.27 7.00 5.56 0.822 6.57 5.46 7.69
C. neoformans AZN 9019 NF NF NF NF NF NF NF NF
A. fumigatus AZN 58 0.802 6.48 6.97 6.00 0.882 5.20 5.03 5.37
A. fumigatus AZN 8196 0.902 6.71 7.25 6.17 0.927 6.31 5.78 6.84
R. microsporus var.
rhizopodiformis AZN 1185
0.855 6.89 7.86 5.91 NF NF NF NF
R. oryzae AZN 6373 NF NF NF NF NF NF NF NF
S. prolificans AZN 7989 NF NF NF NF NF NF NF NF
S. prolificans AZN 7901 NF NF NF NF NF NF NF NF
a For AMB against Candida spp., C. neoformans, and A. fumigatus and for 5FC against C. neoformans and A. fumigatus, data were obtained by nonlinear regression
analysis using the Emax model with variable slopes. For 5FC against Candida spp., data were obtained by linear regression (L). NF, no fit.
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citrate buffer and citrate-phosphate buffer were 0.67 and 0.53
g/ml, respectively, at pH 5.4 and 1.45 and 1.53 g/ml, respec-
tively, at pH 6.0. The mean MICs obtained with citrate-phos-
phate buffer and MOPS were 4.35 and 2.25 g/ml, respectively,
at pH 6.4 and 8 and 8.22 g/ml, respectively, at pH 7.0.
DISCUSSION
In this study, we demonstrated that the in vitro activities of
AMB and 5FC against yeast and mold isolates were pH de-
pendent. The in vitro activity of AMB decreased when the pH
was lowered, while the in vitro activity of 5FC increased when
the pH was lowered. The effect of the pH on the in vitro
activity was dependent not only on the antifungal agent tested
but also on the microorganism tested. Lowering the pH af-
fected the MICs of AMB for all microorganisms in relatively
similar fashions. At acidic pH, all microorganisms appear re-
sistant to AMB. Although this could be due to the lower
activity of AMB at lower pH, another explanation could be the
chemical inactivation of the drug over time. The decreases in
the in vitro activities of AMB against Candida spp., one C.
neoformans isolate, A. fumigatus, and R. microsporus var. rhi-
zopodiformis could be described by sigmoid curves. The sig-
moid curves showed that the decreases in in vitro activities
were primarily found over pH ranges of 7.9 to 5.4 (see the EC20
and EC80 values in Table 2). For the other C. neoformans
isolate and the R. oryzae isolate, the decreases in in vitro
activities could not be confirmed by regression analysis. For S.
prolificans isolates, no relationship was found between the pH
and the in vitro activity of AMB. Lowering the pH affected the
MICs of 5FC for some microorganisms more than for others.
The increase in in vitro activity of 5FC against Candida spp.
could be described by a linear curve, while for one C. neofor-
mans isolate and the A. fumigatus isolates, the increases could
be described by sigmoid curves. The linear curve showed that
the increase in in vitro activity for Candida spp. was found over
a pH range of 7.9 to 4.0, while the sigmoid curves showed that
the increases in in vitro activities for one C. neoformans isolate
and the A. fumigatus isolates were primarily found over a pH
range of 7.7 to 5.0 (see the EC20 and EC80 values in Table 2).
For the other C. neoformans isolate, the increase in in vitro
activity could not be confirmed by regression analysis. For the
Rhizopus sp. and S. prolificans isolates, the relationships be-
tween the pH and the in vitro activities of 5FC could not be
determined because of high off-scale MICs. An explanation for
the increase in the in vitro activity of 5FC could be that pro-
tonation of the NH2 group at low pH leads to a better uptake
of 5FC by the fungal cell.
A limited number of other studies also demonstrated that
the in vitro activities of AMB and 5FC against yeast (Candida
spp. and C. neoformans) and mold isolates (Aspergillus spp.)
were pH dependent (9, 14, 15).
We also demonstrated that the in vitro activity of AMB was
affected by the buffer used, while the in vitro activity of 5FC
was not. For AMB, the MICs found in RPMI 1640 medium
buffered with citrate-phosphate buffer were significantly higher
than the MICs found in RPMI 1640 medium buffered with
MOPS. The difference in MICs was approximately 1 twofold-
dilution step. An explanation for this difference may be that
phosphate buffers are buffers that readily traverse the cell
membrane and can theoretically produce unexpected interac-
tions with antifungal agents (7, 8).
We assume that these differences in MIC do not affect the
pH dependency, since we found that in both RPMI 1640 me-
dium buffered with citrate-phosphate buffer and RPMI 1640
medium buffered with MOPS the in vitro activities of AMB
FIG. 1. Graphic representation of the relationships between the in
vitro activities of amphotericin B and pH values ranging from 4.0 to 7.9
for C. neoformans AZN 467 (A), A. fumigatus AZN 8196 (B), and S.
prolificans AZN 7901 (C).
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against Candida spp., C. neoformans, A. fumigatus, and Rhizo-
pus spp. decreased when the pH was lowered.
The choice of an in vitro susceptibility test and its variables
is based on inter- and intracenter reproducibility, on the ability
to provide a wide range of MICs that allow discrimination
among resistant and sensitive strains, and on the correlation of
in vitro results with clinical outcomes. Buffered medium at a
pH value of 7.0 has been accepted as the standard for the in
vitro susceptibility testing of microorganisms (7, 8). However,
the in vitro results obtained with this standard pH do not
always correlate well with clinical outcome. Viviani et al.
showed that MICs of 5FC against C. neoformans isolates ob-
tained with YNB at pH 5.4 correlated well with clinical out-
come, while MICs obtained with YNB at the standard pH
value of 7.0 did not (15). We also demonstrated that the MICs
of 5FC against A. fumigatus obtained in RPMI 1640 buffered at
a pH value of 5.0 correlated better with in vivo efficacy in a
murine model of invasive aspergillosis than did the MICs ob-
tained in RPMI 1640 buffered at the standard pH value of 7.0
(D. T. A. te Dorsthorst, et al., 44th ICAAC). Thus, there is
some evidence that the predictive value of MICs of 5FC de-
termined at a low pH is greater than those determined at the
standard pH. Further studies will need to confirm this finding
for 5FC. In contrast, the effect of a low pH on the MICs of
AMB was similar for all microorganisms. A discriminatory
effect of pH does not seem to be present.
One of the explanations for the predictive value of MICs of
5FC determined at low pH could be that the pH at the site of
infection is lower than 7.4 (in the human body, the pH is
carefully regulated at pH 7.4), due to the production of organic
acids by fungi (in particular aspergilli) (11). Kauffman et al.
described three different phases during the growth of Aspergil-
lus species (4). These phases could be characterized by changes
in medium pH. During the first phase (phase I), the fungus
starts to grow and uses glucose as a carbon source. The use of
glucose is associated with the production of organic acids and
a resulting drop in medium pH. When glucose becomes lim-
ited, the organic acids are used as a secondary carbon source,
and the medium pH rises again (phase II). After reaching a
maximum, the pH stabilizes or drops slightly (phase III). The
duration of phase I depends on the glucose concentration.
Increasing concentrations of glucose resulted in prolongations
of phase I followed by increases in pH or no increase at all.
Extrapolating these in vitro growth characteristics to the clin-
ical setting, it seems likely that, depending on the concentra-
tion of glucose at the site of infection, the fungus will produce
organic acids and the pH at the site of infection will drop below
7.4. Not only the production of organic acids by fungi but also
FIG. 2. Graphic representation of the relationships between the in vitro activities of flucytosine and pH values ranging from 4.0 to 7.9 for C.
krusei AZN 1_31 (A), C. neoformans AZN 467 (B), A. fumigatus AZN 8196 (C), and S. prolificans AZN 7901 (D).
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the presence of necrosis (12) and the lysozyme activities of
granulocytes and macrophages (3) may lower the pH at the site
of infection.
Unfortunately, the pH values at the site of infection caused
by yeasts or molds are unknown. However, there are some
studies in which the pHs of bacterial abscesses were deter-
mined. The pHs of bacterial abscesses varied, depending on
the location and bacterial agent present, but overall they were
found to be lower than 7.4. One clinical study showed that the
pHs ranged from 5.7 (empyema) to 7.2 (liver abscess) (2), and
another clinical study showed that the pHs of intra-abdominal
and anorectal abscesses ranged between 6 and 6.87 and be-
tween 6 and 6.98, respectively (13). In intra-abdominal ab-
scesses, pH values ranged form 6.71 to 6.85 (1).
We conclude that further studies are necessary to determine
the influence of pH on the distribution of the MICs of several
antifungal agents for various yeasts and molds and on the
correlation between in vitro results with clinical outcome.
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